Thiamine Dosing for Alcohol Withdrawal
All patients with alcohol withdrawal syndrome should receive thiamine 100-300 mg/day before any glucose-containing fluids to prevent Wernicke encephalopathy, with continuation for 2-3 months following resolution of withdrawal symptoms. 1, 2
Acute Phase Dosing
Standard Alcohol Withdrawal (Prophylactic)
- Administer thiamine 100-300 mg/day to all patients with alcohol withdrawal syndrome 1, 2
- The critical timing is to give thiamine before any glucose-containing fluids to avoid precipitating acute thiamine deficiency 2
- For patients receiving IV dextrose, give 100 mg thiamine hydrochloride in each of the first few liters of IV fluid to prevent heart failure 3
Route Selection Based on Risk
- Low-risk patients (uncomplicated alcohol dependence): Oral thiamine 250-500 mg/day for 3-5 days 4
- High-risk patients (severe withdrawal, poor nutrition, history of WE): Parenteral thiamine 250-500 mg/day for 3-5 days 4
- Suspected Wernicke's encephalopathy: Parenteral thiamine 250-300 mg twice daily for 3-5 days 4
- Established Wernicke's encephalopathy: Parenteral thiamine 200-500 mg three times daily for 3-5 days 4
FDA-Approved Dosing for Wernicke-Korsakoff Syndrome
- Initial dose of 100 mg IV, followed by 50-100 mg IM daily until the patient consumes a regular, balanced diet 3
- In emergency cardiac situations ("wet" beriberi), administer slowly by IV route 3
Maintenance Phase Duration
Continue thiamine for 2-3 months following resolution of withdrawal symptoms 1
Transition to Oral Therapy
- After 3-5 days of parenteral therapy, transition to oral thiamine 4
- Low-risk patients: Oral thiamine 100-250 mg/day 4
- High-risk patients: Oral thiamine 250-300 mg/day 4
- Established Wernicke's encephalopathy: Oral thiamine 250-1000 mg/day 4
Critical Timing Considerations
- Treatment should begin within 2 hours of intake for optimal outcomes 5
- Disease progression is significantly dependent on time to treatment, with faster recovery when protocols start earlier regardless of initial presentation 5
- Delayed treatment increases risk of noncompliance with oral management 5
Common Pitfalls to Avoid
- Never administer glucose before thiamine - this can precipitate Wernicke encephalopathy in thiamine-deficient patients 2, 3
- The risk of anaphylactic shock from parenteral thiamine is extremely low (below 1 in 100,000), so fear of adverse reactions should not prevent appropriate treatment 6
- Undertreatment is more dangerous than overtreatment - even protracted cases may respond to aggressive dosing (600 mg/day orally plus 300 mg/day IM) for extended periods 7
- Standard doses may be insufficient for established Wernicke's encephalopathy; doses over 500 mg/day for at least 3 months should be considered in refractory cases 7